Press release
Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports.
Epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease are the most common neurological disorder, which affect the central and peripheral nervous system. These neurological disorders are caused by genetic disorders, congenital abnormalities or disorders, infections, lifestyle or environmental health problems, including malnutrition, and brain injury, spinal cord injury or nerve injury. Bacterial, viral, and fungal infections also responsible for neurological disorders.
Get a Free sample: https://reports.valuates.com/request/sample/ALLI-Auto-4T60/Neuromodulation_Market_by_Technology_Deep_Brain_Stimulation_Sacral_Nerve_Stimulation_Vagus_Nerve_Stimulation_Spinal_Cord_Stimulation_Application_Chronic_Pain_Management_Failed_back_syndrome_Epilepsy_Tremor_Incontinence_Depression_Dystonia_Gastroparesis_Parkinsons_disease_Obsessive_Compulsive_Disorder_Migraine_and_Biomaterial_Metallic_Polymeric_Ceramic_Global_Opportunity_Analysis_and_Industry_Forecast_2014_2022
The increase in prevalence of neurological diseases globally drives the growth of the neuromodulation market. For instance, according to the Epilepsy Action organization, which is the British charity providing information for population with epilepsy, in February 2022, around 600,000 population are diagnosed with epilepsy, in UK, which is around one in every 100 population. In addition, increase in geriatric population propels the growth of neuromodulation market. The increase in R&D activities in the pharmaceutical sector and rise in number of clinical trials in the neuromodulation devices by manufacturers and researchers also contribute in the growth of market. Furthermore, surge in awareness for use of neuromodulation devices further boosts the market growth. The rise in number of hospitals and well-developed healthcare infrastructure further contributes in market growth.
In addition, increase in advancement in technology for neuromodulation devices and rise in product launch in the field of neuromodulation devices contribute in the growth of the neuromodulation market. However, the high cost of neuromodulation devices are expected to limit the growth of market.
Global Neuromodulation Market Segmentation
The neuromodulation market is segmented on the basis of technology, application, biomaterial, and region. By technology, the market is mainly categorized into internal neuromodulation and external neuromodulation. By application, it is categorized in chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson disease, epilepsy, tremor, depression, and other applications. On the basis of biomaterial, it is divided into, metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Abbott, Aleva, Neurotherapeutics SA., Boston Scientific Corporation, LivaNova, Medtronic, MicroTransponder, Neuronetics, NeuroPace Inc., NeuroSigma, and Nevro Corporation.
View full Report:https://reports.valuates.com/market-reports/ALLI-Auto-4T60/neuromodulation
KEY BENEFITS FOR STAKEHOLDERS
• The report provides an in-depth analysis of the global neuromodulation market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global neuromodulation market growth.
Neuromodulation Market Segmentation
By Technology
• Internal Neuromodulation
• External Neuromodulation
By Application
• Chronic Pain
• Urinary And Fecal Incontinence
• Migraine
• Failed Back Syndrome
• Parkinson Disease
• Epilepsy
• Tremor
• Depression
• Other Applications
By Biomaterial
• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramic Biomaterials
By Region
• North America
• Europe
• Asia-Pacific
• LAMEA
Key Market Players
• LivaNova PLC
• Nevro Corporation
• Medtronic
• NeuroSigma
• Neuronetics
• Bioventus Inc.
• NeuroPace Inc
• MicroTransponder
• MicroTransponder
• Boston Scientific Corporation
• Abbot
Inquire For Regional Reports: https://reports.valuates.com/request/regional/ALLI-Auto-4T60/Neuromodulation_Market_by_Technology_Deep_Brain_Stimulation_Sacral_Nerve_Stimulation_Vagus_Nerve_Stimulation_Spinal_Cord_Stimulation_Application_Chronic_Pain_Management_Failed_back_syndrome_Epilepsy_Tremor_Incontinence_Depression_Dystonia_Gastroparesis_Parkinsons_disease_Obsessive_Compulsive_Disorder_Migraine_and_Biomaterial_Metallic_Polymeric_Ceramic_Global_Opportunity_Analysis_and_Industry_Forecast_2014_2022
Similar Reports:
1. Deep Brain Stimulation System Market : https://reports.valuates.com/market-reports/QYRE-Auto-20Y3138/global-deep-brain-stimulation-system
2. Overactive Bladder Treatment Device Market : https://reports.valuates.com/market-reports/QYRE-Auto-33P11666/global-overactive-bladder-treatment-device
3. Medical RF Lesion Generator Market: https://reports.valuates.com/market-reports/QYRE-Auto-12D11466/global-medical-rf-lesion-generator
4. Radiofrequency Ablation Instrument Market: https://reports.valuates.com/market-reports/QYRE-Auto-19O7278/global-radiofrequency-ablation-instrument
5. Pain Management RF Lesion Generator Market : https://reports.valuates.com/market-reports/QYRE-Auto-31Z11171/global-pain-management-rf-lesion-generator
Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137
Email Id:
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports. here
News-ID: 2746866 • Views: …
More Releases from Valuates Reports
Wafer Inspection Microscope Market Share Driven by Advancements in Semiconductor …
Wafer Inspection Microscope Market Size
The global market for Wafer Inspection Microscope was valued at US$ 510 million in the year 2024 and is projected to reach a revised size of US$ 842 million by 2031, growing at a CAGR of 7.1% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-5X17759/Global_Wafer_Inspection_Microscope_Market_Research_Report_2024
The Wafer Inspection Microscope Market continues to expand as semiconductor manufacturers pursue higher precision and tighter process control to improve wafer quality and device…
Semiconductor Wafer Test Probe Cards Market Share Driven by High-Performance IC …
Semiconductor Wafer Test Probe Cards Market Size
The global market for Semiconductor Wafer Test Probe Cards was valued at US$ 2973 million in the year 2024 and is projected to reach a revised size of US$ 4580 million by 2031, growing at a CAGR of 6.5% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-1X13178/Global_Semiconductor_Wafer_Test_Probe_Cards_Market_Research_Report_2023
The Semiconductor Wafer Test Probe Cards market is experiencing steady market growth as global wafer fabrication expands and advanced integrated…
Wafer Test Probe Cards Market Share Driven by Semiconductor Process Scaling and …
Wafer Test Probe Cards Market Size
The global market for Wafer Test Probe Cards was valued at US$ 2814 million in the year 2024 and is projected to reach a revised size of US$ 4354 million by 2031, growing at a CAGR of 6.5% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-6A12711/Global_Wafer_Test_Probe_Cards_Market_Research_Report_2022
The Wafer Test Probe Cards market is witnessing strong market growth as semiconductor manufacturers accelerate production of advanced logic, memory, and high-performance…
Profilometers Market Share Driven by Rising Precision Manufacturing Requirements …
Profilometers Market Size
The global market for Profilometers was valued at US$ 427 million in the year 2024 and is projected to reach a revised size of US$ 548 million by 2031, growing at a CAGR of 3.7% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-37Y12016/Global_Profilometers_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028
The Profilometers market is experiencing strong market growth as manufacturers across electronics, automotive, semiconductor, and mechanical engineering sectors increase focus on precision surface measurement and dimensional accuracy. Market…
More Releases for Neuromodulation
Rising Prevalence Of Neurological Disorders Fuels Growth In The Neuromodulation …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Neuromodulation Market Size By 2025?
In the recent years, the neuromodulation market size has seen robust growth. The market, worth $6.96 billion in 2024, is anticipated to increase to $7.62 billion in 2025 - a compound annual growth rate (CAGR) of 9.5%. Factors such as…
Neuromodulation Market worth $10.4 billion by 2027
Neuromodulation Market is projected to grow from USD 6.0 billion in 2022 to USD 10.4 billion by 2027, at a CAGR of 11.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. The market is driven by government support for research on neurological disorder along with increasing prevalence of neurological disorders. Emerging economies are expected to provide lucrative growth opportunities for the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
The internal neuromodulation…
Neuromodulation Market: Charting Future Frontiers for 2030
The Neuromodulation market was valued USD 6.5 Billion in 2023 and projected to reach USD 15.3 Billion by 2030, growing at a CAGR of 13.0% during the forecast period of 2024-2030.
The Neuromodulation Market report studies the competitive environment of the Neuromodulation Market based on company profiles and their efforts to increase product value and production. The Neuromodulation Market report discusses various factors driving or restraining the market, which will help…
Incontinence Neuromodulation Market - Reclaiming Independence, Redefining Well-b …
Newark, New Castle, USA: The "Incontinence Neuromodulation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Incontinence Neuromodulation Market: https://www.growthplusreports.com/report/incontinence-neuromodulation-market/8696
This latest report researches the industry structure, sales, revenue,…
Neuromodulation Devices Market Insights, Forecast to 2030
The report extensively examines the global Neuromodulation Devices market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Neuromodulation Devices . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market…
Neuromodulation Market Outlook 2022-2028
Neurological issues are characterized as problems that influence the mind as well as the nerves tracked down all through the human body and the spinal rope. Intense spinal line injury, Alzheimer's sickness, amyotrophic horizontal sclerosis (ALS), ataxia, chime paralysis, mind cancers, cerebral aneurysm, epilepsy, and seizures are a portion of the normal neurological issues. The biochemical, underlying, or electrical irregularities in the mind, spinal line, or different nerves bring about…
